{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"vitamin-k-antagonist-embryofetopathy","columns":[{"gene":"","key":"population-323aa568148f95cbec0f","label":"Vitamin K antagonist embryofetopathy","mondoId":"MONDO:0016010","onsetQualifier":null,"originColumnKey":"MONDO:0016010/ORPHA:1914","originalViews":[{"key":"MONDO:0016010/ORPHA:1914","label":"Vitamin K antagonist embryofetopathy","scopeLabel":"ORPHA:1914","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["22608260ea4fcce83804947f6151c5eaf0afd4edd191734759e7c0b90527e96c","245e0902a0a867fe727f937c2aa07e5143f0cb678f7c51c7b2c8c1dc8f0ced45","28aa95fa6d1db57f5c7fdf42fd9b6ef618fafee77baf919326c32530842b8968","2938122abef282415e3e529d08d29091db61df286ecb41c882d8037cf3c7b2ae","2a142b6c2c38b55fdc9495f9e143285e9bca2586374efea608e9f1aa3b33b658","33d42e81a704748409e86f8c72a931f8accf4618512b2d80b0c3c633920722b4","3fe1fcf0a618963d441354f128ccfd2128a468b445b78d30e51925c4226aa49a","48999794984df79b46ab686eaae8210ed88243265abfddcf740a7e5ff56cccd6","4e1b4454461ccbbb414b6ae367714ac7302f2815f4bd9fea5bb05cd7510ad8f1","59b0b327ea9abc5f9856c2e216de7c44afc18b3bdc6eaba14c9c15bef9fd4b07","63726d2b9dece0660bcb796ef074c69d677e6a05e990142c57b4ee3ae109bd0e","681cb506632b15bcb4a0254840d2f139437cc5008045fdd799b3bb7805fdb7f7","6c3203a6f4bbb4cba076b364da95b0a34d5478604e4945aff4d87c278b06f052","6f2da8879273f0ac624de6b53ee4d38dcda8d9800e484fdbb4195346137c52a7","71c03ce34fe33f8520d826c625f49cece70d76b47a6359c5e93f71188d5a8cf1","756c98d61ed242cf00868e36fc39e206b9f457b257005afb48261bda3be98126","765cb124913bde1a9ac0a3c4fddb353365b1f8968e196b3e9ddb947972d4eaeb","82e8f71b5e5e11465d4fd72d3176fbd6ea732a08094c3ca9f5cb3c2f844a1052","93bc39419b04d34786f36c3d407b30e2672d83bf60da4d1ee79bc56f2bf4cbff","a93caed67a3e31c2cdd73154c94958505d738708eb992e398dbf00c7960ef8fc","abd9817c3efda82748e637cd30595236d398a7c06c96c65550956427a72ff177","af026719b42b7d767ee7c1e8390187f3fd1bbb0d83fe3abd462a465e24cc80b4","c84137c2f27b05885dd86dcaa3508adb73e6f72762bb9d7f47d3988a8aa5b50b","deea0a5e7d457ddbc053b0017be675c6c576eae4bfd7bce296a0f6430aca0343","ebb385636ae046fd9edfba4786baa4e58efa0b836c75c785a09a7b986f4f30d4","f5d5893a5c6c662bfe5f24d7f0670f73e95601a68eeaf025f9b7ad82ebe4093f"],"recordQualifiers":{},"scopeLabel":"ORPHA:1914","sourceIds":["ORPHA:1914"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-323aa568148f95cbec0f"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0030680","HP:0000463","HP:0008056","HP:0001156","HP:0000518","HP:0000453","HP:0005280"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":26,"sourceGroups":{"orphanet":26}},"features":[{"hpoId":"HP:0030680","label":"Abnormal cardiovascular system morphology","primary":true},{"hpoId":"HP:0000463","label":"Anteverted nares","primary":true},{"hpoId":"HP:0008056","label":"Aplasia/Hypoplasia affecting the eye","primary":true},{"hpoId":"HP:0001156","label":"Brachydactyly","primary":true},{"hpoId":"HP:0000518","label":"Cataract","primary":true},{"hpoId":"HP:0000453","label":"Choanal atresia","primary":true},{"hpoId":"HP:0005280","label":"Depressed nasal bridge","primary":true},{"hpoId":"HP:0010655","label":"Epiphyseal stippling","primary":false},{"hpoId":"HP:0000365","label":"Hearing impairment","primary":false},{"hpoId":"HP:0000238","label":"Hydrocephalus","primary":false},{"hpoId":"HP:0000316","label":"Hypertelorism","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0001511","label":"Intrauterine growth retardation","primary":false},{"hpoId":"HP:0000158","label":"Macroglossia","primary":false},{"hpoId":"HP:0008551","label":"Microtia","primary":false},{"hpoId":"HP:0002475","label":"Myelomeningocele","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0000520","label":"Proptosis","primary":false},{"hpoId":"HP:0008420","label":"Punctate vertebral calcifications","primary":false},{"hpoId":"HP:0002093","label":"Respiratory insufficiency","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0009882","label":"Short distal phalanx of finger","primary":false},{"hpoId":"HP:0000470","label":"Short neck","primary":false},{"hpoId":"HP:0003196","label":"Short nose","primary":false},{"hpoId":"HP:0000505","label":"Visual impairment","primary":false}],"ledeHtml":"A teratogenic disorder observed in a newborn or child of a mother who was exposed to warfarin during pregnancy. Manifestations include nasal bridge depression, nasal bones hypoplasia, microcephaly, congenital heart disorders, and brachydactyly.","mondoId":"MONDO:0016010","node":{"canonicalSlug":"vitamin-k-antagonist-embryofetopathy","comparisons":[{"documentSha256":"c6473519017e870faadc8575fdf4edc4aea28829e3bbca529e6b6e7c94edc8df","key":"legacy-vitamin-k-antagonist-embryofetopathy","kind":"legacy","label":"vitamin K-antagonist embryofetopathy","memberIds":["MONDO:0016010"],"mondoId":"MONDO:0016010","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/vitamin-k-antagonist-embryofetopathy.c6473519017e870faadc8575fdf4edc4aea28829e3bbca529e6b6e7c94edc8df.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"vitamin K-antagonist embryofetopathy","paragraphs":["A teratogenic disorder observed in a newborn or child of a mother who was exposed to warfarin during pregnancy. Manifestations include nasal bridge depression, nasal bones hypoplasia, microcephaly, congenital heart disorders, and brachydactyly."],"scope":"exact","source":"MONDO","upstream":"NCIT:C98906","url":"https://monarchinitiative.org/MONDO:0016010"},"ownColumnKeys":["population-323aa568148f95cbec0f"],"publication":"published","relationships":[{"kind":"parent","label":"syndromic disease","mondoId":"MONDO:0002254","slug":null},{"kind":"parent","label":"toxic or drug-related embryofetopathy","mondoId":"MONDO:0016677","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"22608260ea4fcce83804947f6151c5eaf0afd4edd191734759e7c0b90527e96c","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000470","is_excluded":false,"label":"Short neck","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"245e0902a0a867fe727f937c2aa07e5143f0cb678f7c51c7b2c8c1dc8f0ced45","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"28aa95fa6d1db57f5c7fdf42fd9b6ef618fafee77baf919326c32530842b8968","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0009882","is_excluded":false,"label":"Short distal phalanx of finger","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2938122abef282415e3e529d08d29091db61df286ecb41c882d8037cf3c7b2ae","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000158","is_excluded":false,"label":"Macroglossia","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2a142b6c2c38b55fdc9495f9e143285e9bca2586374efea608e9f1aa3b33b658","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0010655","is_excluded":false,"label":"Epiphyseal stippling","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"33d42e81a704748409e86f8c72a931f8accf4618512b2d80b0c3c633920722b4","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008056","is_excluded":false,"label":"Aplasia/Hypoplasia affecting the eye","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3fe1fcf0a618963d441354f128ccfd2128a468b445b78d30e51925c4226aa49a","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001511","is_excluded":false,"label":"Intrauterine growth retardation","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"48999794984df79b46ab686eaae8210ed88243265abfddcf740a7e5ff56cccd6","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003196","is_excluded":false,"label":"Short nose","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4e1b4454461ccbbb414b6ae367714ac7302f2815f4bd9fea5bb05cd7510ad8f1","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"59b0b327ea9abc5f9856c2e216de7c44afc18b3bdc6eaba14c9c15bef9fd4b07","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000453","is_excluded":false,"label":"Choanal atresia","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"63726d2b9dece0660bcb796ef074c69d677e6a05e990142c57b4ee3ae109bd0e","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000463","is_excluded":false,"label":"Anteverted nares","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"681cb506632b15bcb4a0254840d2f139437cc5008045fdd799b3bb7805fdb7f7","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000520","is_excluded":false,"label":"Proptosis","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6c3203a6f4bbb4cba076b364da95b0a34d5478604e4945aff4d87c278b06f052","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001156","is_excluded":false,"label":"Brachydactyly","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6f2da8879273f0ac624de6b53ee4d38dcda8d9800e484fdbb4195346137c52a7","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000316","is_excluded":false,"label":"Hypertelorism","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"71c03ce34fe33f8520d826c625f49cece70d76b47a6359c5e93f71188d5a8cf1","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000365","is_excluded":false,"label":"Hearing impairment","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"756c98d61ed242cf00868e36fc39e206b9f457b257005afb48261bda3be98126","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002475","is_excluded":false,"label":"Myelomeningocele","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"765cb124913bde1a9ac0a3c4fddb353365b1f8968e196b3e9ddb947972d4eaeb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"82e8f71b5e5e11465d4fd72d3176fbd6ea732a08094c3ca9f5cb3c2f844a1052","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0030680","is_excluded":false,"label":"Abnormal cardiovascular system morphology","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"93bc39419b04d34786f36c3d407b30e2672d83bf60da4d1ee79bc56f2bf4cbff","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0008420","is_excluded":false,"label":"Punctate vertebral calcifications","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a93caed67a3e31c2cdd73154c94958505d738708eb992e398dbf00c7960ef8fc","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"abd9817c3efda82748e637cd30595236d398a7c06c96c65550956427a72ff177","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000518","is_excluded":false,"label":"Cataract","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"af026719b42b7d767ee7c1e8390187f3fd1bbb0d83fe3abd462a465e24cc80b4","raw":{"aspect":"P","body_system":"ear","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0008551","is_excluded":false,"label":"Microtia","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c84137c2f27b05885dd86dcaa3508adb73e6f72762bb9d7f47d3988a8aa5b50b","raw":{"aspect":"P","body_system":"respiratory","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002093","is_excluded":false,"label":"Respiratory insufficiency","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"deea0a5e7d457ddbc053b0017be675c6c576eae4bfd7bce296a0f6430aca0343","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000238","is_excluded":false,"label":"Hydrocephalus","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ebb385636ae046fd9edfba4786baa4e58efa0b836c75c785a09a7b986f4f30d4","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000505","is_excluded":false,"label":"Visual impairment","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f5d5893a5c6c662bfe5f24d7f0670f73e95601a68eeaf025f9b7ad82ebe4093f","raw":{"aspect":"P","body_system":"head_and_neck","disease_id":"ORPHA:1914","disease_name":"Vitamin K antagonist embryofetopathy","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0005280","is_excluded":false,"label":"Depressed nasal bridge","onset_id":null,"reference":"ORPHA:1914","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0016010\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>NCIT:C98906</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A teratogenic disorder observed in a newborn or child of a mother who was exposed to warfarin during pregnancy. Manifestations include nasal bridge depression, nasal bones hypoplasia, microcephaly, congenital heart disorders, and brachydactyly.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0016010\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"vitamin-k-antagonist-embryofetopathy","sourceDocuments":[{"name":"MONDO: vitamin K-antagonist embryofetopathy","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0016010"}],"sourceNote":"","synonyms":["congenital warfarin syndrome","coumarin embryopathy","coumarin syndrome","di Sala syndrome","DiSala syndrome","embryofetopathy due to oral anticoagulant therapy","fetal anticoagulant syndrome","fetal Coumadin syndrome","fetal warfarin syndrome","foetal anticoagulant syndrome","foetal Coumadin syndrome","foetal warfarin syndrome","vitamin K antagonist embryopathy","vitamin K antagonists embryofetopathy","vitamin K-antagonist embryofetopathy","vitamin K-antagonist embryopathy","warfarin embryofetopathy","warfarin embryopathy","warfarin syndrome"],"takeawayHtml":"","title":"vitamin K-antagonist embryofetopathy"},"schemaVersion":1}
